Loomis, Sayles & Company
AHCO icon

Loomis, Sayles & Company’s AdaptHealth AHCO Stock Holding History

Loomis, Sayles & Company’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-631,976
Closed -$5.75M – 969
2023
Q3 		$5.75M Buy
+631,976
New +$7.57M 0.01% 381

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Loomis, Sayles & Company's AHCO Position: Q4 2023 in Review

Loomis, Sayles & Company sold out of AdaptHealth (AHCO) in Q4 2023, closing a stake of 631,976 shares — an estimated $5.75M sold.

Loomis, Sayles & Company first reported a position in AHCO in Q3 2023 and held it in 1 quarter. The position peaked at $5.75M in Q3 2023. 192 funds tracked by Wall St. Rank hold AHCO as of Q4 2023.

  • Loomis, Sayles & Company reported no remaining AdaptHealth position as of Q4 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 631,976 AdaptHealth shares in Q4 2023, an estimated $5.75M.
  • Loomis, Sayles & Company first reported a position in AdaptHealth in Q3 2023 and held it in 1 quarter.
  • Loomis, Sayles & Company's AdaptHealth position peaked at $5.75M in Q3 2023.
  • 192 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2023.

Based on Loomis, Sayles & Company's 13F filing for Q4 2023, filed 13 Feb 2024.